All Stories

  1. Breaking the skin barrier: How nanoparticle-loaded microneedles are poised to redefine drug delivery
  2. Inhaled Virus-Mimicking Particles Elicit Dose-Dependent Immune Response against SARS-CoV-2 with Sex-Bias ACE2 Activity in Mice
  3. Quercetin nanoemulsion ameliorates key hallmarks of lung cancer
  4. The multiverse of zebrafish within the nanoworld
  5. Hybrid Physics-Informed and Bayesian Modeling of Single-Nanoparticle–Cell Adhesion Kinetics under Cytoskeletal Perturbation
  6. Nano-in-Micro GelMA depots assist electro-thermal-immuno orchestral treatment for solid triple negative breast tumor
  7. Co-precipitation of quercetin and lignin: unveiling phenolic fruit-derived extracts encapsulation
  8. Chemosensitizer Effects of Coencapsulation of Curcumin and Cabazitaxel in Nanostructured Lipid Carriers in Glioblastoma Cells
  9. Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine
  10. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
  11. Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue
  12. Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease
  13. A Review of Current Computational Tools for Peptide–Protein Docking
  14. Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel
  15. Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design
  16. Nanoparticle‐Mediated Delivery of Adenosine 5′‐Monophosphate Enhances 5‐Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure
  17. A Microneedle with Photoactive Electrospun Backing Layer Enables Multitherapy and Combined Drug Delivery to the Skin Wound
  18. Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models
  19. Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery
  20. Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance
  21. A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on
  22. Design and in vitro validation of Brome mosaic –virus-like particles for gene delivery and immunomodulation of melanoma
  23. Quantum sensing of free radicals in macrophages reveals early autophagy-lysosome regulation in an atherosclerosis cell model
  24. Nanoencapsulated flavonoids for enhanced modulation of the microbiota-gut-brain axis and neurodegenerative add-on therapy
  25. PS8.2: Deciphering the Role of Amphiregulin in AEC-Derived Microvesicles: Implications for Immune Regulation and Regenerative Medicine.
  26. Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
  27. Outside Front Cover
  28. Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering
  29. Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
  30. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials
  31. Organ-on-Chip Platforms for Nanoparticle Toxicity and Efficacy Assessment: Advancing Beyond Traditional In Vitro and In Vivo Models
  32. Revolutionizing Chemotherapy Control using Black Hole Inspired Dynamics
  33. Metal-organic frameworks in sample preparation for clinical applications – A review
  34. Artificial cells and biomimicry cells: A rising star in the fight against cancer
  35. Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis
  36. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens
  37. Integrated Microfluidic Chip for Neutrophil Extracellular Vesicle Analysis and Gastric Cancer Diagnosis
  38. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
  39. Biological Augmentation Using Electrospun Constructs with Dual Growth Factor Release for Rotator Cuff Repair
  40. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
  41. H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
  42. Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming
  43. Local glycolysis-modulating hydrogel microspheres for a combined anti-tumor and anti-metastasis strategy through metabolic trapping strategy
  44. Reactive oxygen species switcher via MnO2-coated Prussian blue loaded hyaluronic acid methacrylate hydrogel microspheres for local anti-tumor treatment
  45. Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord
  46. Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis
  47. Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method
  48. Development of Amniotic Epithelial Stem Cells Secretome-Loaded In Situ Inverse Electron Demand Diels–Alder-Cross-Linked Hydrogel as a Potential Immunomodulatory Therapeutical Tool
  49. Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
  50. Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells
  51. Hijacking plant skeletons for biomedical applications: from regenerative medicine and drug delivery to biosensing
  52. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
  53. Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis
  54. Preface
  55. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders
  56. A Near-Infrared Light Absorbable Hydrogel with Antibacterial Effect for Mild Photothermal Regeneration of Infected Wounds
  57. Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification
  58. A study of the oral bioavailability and biodistribution increase of Nanoencapsulation-driven Delivering radiolabeled anthocyanins
  59. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
  60. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  61. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo
  62. Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
  63. Electrochemical detection of atrial natriuretic peptide-coated nanocarriers based on a molecularly imprinted polymer receptor thin film
  64. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
  65. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
  66. A translational framework to DELIVER nanomedicines to the clinic
  67. Breaking barriers: The potential of nanosystems in antituberculosis therapy
  68. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management
  69. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  70. Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction
  71. Unlocking the potential of nanomedicine: advances in precision targeting strategies
  72. Front Cover: Nano Select 7–8 / 2024
  73. Self‐Nanoformulating Poly(2‐oxazoline) and Poly(2‐oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  74. Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes
  75. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
  76. Special Issue on Advances in Porous Materials
  77. Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy
  78. Implantable Patch of Oxidized Nanofibrillated Cellulose and Lysozyme Amyloid Nanofibrils for the Regeneration of Infarcted Myocardium Tissue and Local Delivery of RNA‐Loaded Nanoparticles
  79. Lipid nanoparticles-based RNA therapies for breast cancer treatment
  80. Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  81. Curcuma Longa: Nutraceutical Use and Association With Nanotechnology
  82. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
  83. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  84. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy
  85. In Situ Biofabrication of Microbial Cellulose Capsules Carrying Cubosomes: Toward Colon Targeted Multidrug Delivery
  86. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
  87. Physicochemical characterization of a lycopene‐loaded mesoporous silica nanoparticle formulation
  88. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
  89. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
  90. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs
  91. Engineering and Targeting Neutrophils for Cancer Therapy
  92. Porous Silicon Nanoparticles Conjugated Magnetite‐Chitosan Graphene Oxide Nanoparticles for Effective Removal of Complex Pollutants
  93. Inside Back Cover
  94. Diatom-guided bone healing via a hybrid natural scaffold
  95. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide
  96. Quantum Sensing of Free Radical Generation in Mitochondria of Single Heart Muscle Cells during Hypoxia and Reoxygenation
  97. Porous Si-Based Nanosystems for Immunotherapy Applications
  98. Noninvasive Novel Transdermal Drug Delivery System for Deep Drug Permeability
  99. Cell-based in vitro models for buccal permeability studies
  100. Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
  101. Diversity-oriented combinatory formulation screen for cardiac RNAi therapeutics with polysaccharide framework
  102. Polyethylene Glycol‐Stabilized Gold Nanostars‐Loaded Microneedles for Photothermal Therapy of Melanoma
  103. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy (Adv. Funct. Mater. 46/2023)
  104. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  105. Advanced porous materials for antimicrobial treatment
  106. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
  107. Mycophenolic Acid-loaded Naïve Macrophage-derived Extracellular Vesicles Rescue Cardiac Myoblast after Inflammatory Injury
  108. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  109. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  110. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
  111. Development of a time-dependent oral colon delivery system of anaerobic Odoribacter splanchnicus for bacteriotherapy
  112. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study (Adv. Funct. Mater. 34/2023)
  113. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy
  114. Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
  115. Development of fast dissolving polymer-based microneedles for delivery of an antigenic melanoma cell membrane
  116. Double‐Layered Polyvinylpyrrolidone–Poly(methyl vinyl ether‐alt‐maleic acid)‐Based Microneedles to Deliver Meloxicam: An In Vitro, In Vivo, and Short‐Term Stability Evaluation Study
  117. In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
  118. Fabricated technology of biomedical micro-nano hydrogel
  119. Multifunctional nanostructures: Intelligent design to overcome biological barriers
  120. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study
  121. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study
  122. Injectable Nanocomposite Hydrogels of Gelatin-Hyaluronic Acid Reinforced with Hybrid Lysozyme Nanofibrils-Gold Nanoparticles for the Regeneration of Damaged Myocardium
  123. In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
  124. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  125. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  126. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  127. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  128. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  129. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  130. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  131. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  132. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  133. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  134. Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems
  135. Fabrication of hydrogel microspheres via microfluidics using inverse electron demand Diels–Alder click chemistry-based tetrazine-norbornene for drug delivery and cell encapsulation applications
  136. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  137. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  138. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  139. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  140. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  141. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  142. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  143. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  144. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  145. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  146. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  147. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  148. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  149. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  150. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  151. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  152. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  153. Functional biomaterials
  154. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  155. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  156. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  157. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  158. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  159. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  160. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  161. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  162. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  163. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  164. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  165. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  166. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  167. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  168. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  169. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  170. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  171. Programmable immune activating electrospun fibers for skin regeneration
  172. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  173. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  174. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  175. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  176. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  177. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  178. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  179. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  180. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  181. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  182. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  183. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  184. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  185. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  186. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  187. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  188. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  189. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  190. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  191. Engineered Extracellular Vesicles for Cancer Therapy
  192. Development of vaccine formulations: past, present, and future
  193. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  194. Microneedles for painless transdermal immunotherapeutic applications
  195. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  196. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  197. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  198. Front cover
  199. Advanced Nanosystems for Clinical Translation
  200. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  201. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  202. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  203. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  204. Front Matter
  205. Introduction to lignocellulosic materials
  206. Requirements and properties of biomaterials for biomedical applications
  207. Bio-Nanomedicine for Cancer Therapy
  208. Porous Silicon for Biomedical Applications
  209. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  210. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  211. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  212. Recent progress in the design of DNA vaccines against tuberculosis
  213. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  214. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  215. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  216. Requirements for Animal Experiments: Problems and Challenges
  217. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  218. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  219. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  220. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  221. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  222. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  223. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  224. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  225. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  226. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  227. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  228. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  229. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  230. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  231. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  232. The solid progress of nanomedicine
  233. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  234. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  235. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  236. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  237. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  238. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  239. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  240. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  241. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  242. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  243. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  244. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  245. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  246. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  247. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  248. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  249. Novel RET agonist for the treatment of experimental neuropathies
  250. Oral drug delivery: Overview
  251. Spray-drying for the formulation of oral drug delivery systems
  252. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  253. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  254. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  255. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  256. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  257. Cover Image
  258. Nanotechnology for Oral Drug Delivery
  259. Nanomedicine Therapies
  260. Handbook of In Vivo Chemistry in Mice
  261. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  262. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  263. Artificially cloaked viral nanovaccine for cancer immunotherapy
  264. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  265. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  266. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  267. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  268. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  269. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  270. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  271. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  272. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  273. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  274. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  275. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  276. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  277. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  278. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  279. On the issue of transparency and reproducibility in nanomedicine
  280. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  281. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  282. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  283. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  284. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  285. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  286. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  287. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  288. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  289. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  290. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  291. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  292. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  293. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  294. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  295. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  296. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  297. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  298. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  299. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  300. Photosensitive materials for constructing on-demanded drug-release systems
  301. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  302. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  303. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  304. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  305. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  306. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  307. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  308. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  309. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  310. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  311. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  312. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  313. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  314. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  315. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  316. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  317. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  318. Materials Science in Finland
  319. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  320. Materials Science in Finland: (Adv. Mater. 24/2018)
  321. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  322. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  323. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  324. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  325. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  326. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  327. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  328. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  329. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  330. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  331. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  332. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  333. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  334. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  335. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  336. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  337. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  338. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  339. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  340. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  341. 3D printing: prospects and challenges
  342. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  343. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  344. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  345. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  346. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  347. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  348. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  349. Non-invasive strategies for targeting the posterior segment of eye
  350. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  351. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  352. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  353. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  354. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  355. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  356. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  357. Surface modification of acetaminophen particles by atomic layer deposition
  358. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  359. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  360. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  361. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  362. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  363. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  364. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  365. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  366. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  367. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  368. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  369. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  370. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  371. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  372. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  373. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  374. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  375. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  376. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  377. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  378. Springer Handbook of Nanotechnology
  379. Nano-Particles for Biomedical Applications
  380. Inside Cover Image, Volume 9, Issue 1
  381. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  382. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  383. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  384. Microparticles to enhance delivery of drugs and growth factors into wound sites
  385. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  386. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  387. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  388. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  389. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  390. Microfluidics as a cutting-edge technique for drug delivery applications
  391. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  392. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  393. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  394. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  395. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  396. Applications of bacterial cellulose in food, cosmetics and drug delivery
  397. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  398. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  399. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  400. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  401. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  402. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  403. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  404. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  405. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  406. Chemotherapy with Porous Silicon
  407. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  408. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  409. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  410. Copolymers: Drug Delivery
  411. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  412. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  413. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  414. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  415. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  416. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  417. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  418. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  419. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  420. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  421. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  422. Diatomite nanoparticles as potential drug delivery systems
  423. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  424. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  425. Multifunctional porous silicon nanoparticles for cancer theranostics
  426. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  427. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  428. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  429. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  430. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  431. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  432. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  433. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  434. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  435. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  436. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  437. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  438. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  439. Revolutionary impact of nanovaccines on immunotherapy
  440. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  441. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  442. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  443. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  444. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  445. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  446. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  447. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  448. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  449. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  450. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  451. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  452. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  453. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  454. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  455. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  456. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  457. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  458. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  459. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  460. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  461. Biocompatibility of porous silicon for biomedical applications
  462. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  463. Preface
  464. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  465. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  466. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  467. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  468. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  469. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  470. Drug delivery with nanostructured porous silicon nanoparticles
  471. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  472. Metabolism of the Antituberculosis Drug Ethionamide
  473. Porous Silicon Nanoparticles
  474. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  475. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  476. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  477. Encyclopedia of Metalloproteins
  478. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  479. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  480. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  481. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  482. Porous-based biomaterials for tissue engineering and drug delivery applications
  483. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  484. Toxicological Profile of Therapeutic Nanodelivery Systems
  485. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  486. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  487. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  488. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  489. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  490. Nanoparticulate targeted drug delivery using peptides and proteins
  491. Cellular interactions of surface modified nanoporous silicon particles
  492. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  493. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  494. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  495. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  496. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  497. 4th BBBB International Conference on Pharmaceutical Sciences
  498. Poster Presentation
  499. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  500. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  501. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  502. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  503. Mesoporous materials as controlled drug delivery formulations
  504. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  505. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  506. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  507. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  508. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  509. Biocompatibility of mesoporous silicon microparticles
  510. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  511. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  512. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  513. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  514. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  515. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  516. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  517. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  518. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  519. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  520. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery